NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 39
Auteur Titel [ Jaar(Asc)]
Filters: Trefwoord is Female  [Alle filters opschonen]
2019
Arends RM, Nelwan EJ, Soediro R, van Crevel R, Alisjahbana B, Pohan HT, A von Borries KL, Schene AH, Van der Ven AJAM, Schellekens AFA.  2019.  Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study. PLoS One. 14(2):e0207970.
van den Brink WGMoerman-, van Aken L, Verschuur EML, Walvoort SJW, Egger JIM, Kessels RPC.  2019.  Executive Dysfunction in Patients With Korsakoff's Syndrome: A Theory-Driven Approach. Alcohol Alcohol. 54(1):23-29.
2018
Kraan AEM, Dijkstra BAG, Markus W.  2018.  Treatment delivery of the community reinforcement approach in outpatient addiction treatment.. Eval Program Plann. 70:61-66.
2016
Kiewik M, VanDerNagel JEl, Kemna LEM, Engels RCME, DeJong CA.  2016.  Substance use prevention program for adolescents with intellectual disabilities on special education schools: a cluster randomised control trial.. J Intellect Disabil Res. 60(3):191-200.
2014
Pujol J, Blanco-Hinojo L, Batalla A, López-Sola C, Harrison BJ, Soriano-Mas C, Crippa JA, Fagundo AB, Deus J, de la Torre R et al..  2014.  Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users.. J Psychiatr Res. 51:68-78.
2013
Barrio P, Batalla A, Castellví P, Hidalgo D, García M, Ortiz A, Grande I, Pons A, Parellada E.  2013.  Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.. Int Clin Psychopharmacol. 28(4):164-70.
Qurishi R, Sonneborn C, de Jong-Arts M, DeJong CA.  2013.  Premenstrual syndrome and self-medication with opioids.. J Addict Med. 7(1):79-82.
Batalla A, Garcia-Rizo C, Castellví P, Fernandez-Egea E, Yücel M, Parellada E, Kirkpatrick B, Martin-Santos R, Bernardo M.  2013.  Screening for substance use disorders in first-episode psychosis: implications for readmission.. Schizophr Res. 146(1-3):125-31.
Batalla A, Bhattacharyya S, Yücel M, Fusar-Poli P, Crippa JA, Nogué S, Torrens M, Pujol J, Farré M, Martin-Santos R.  2013.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.. PLoS One. 8(2):e55821.
Kok T, de Haan HA, van der Velden HJW, van der Meer M, Najavits LM, DeJong CA.  2013.  Validation of two screening instruments for PTSD in Dutch substance use disorder inpatients.. Addict Behav. 38(3):1726-31.
2012
Carpentier PJ, Knapen LJM, Van Gogh MT, Buitelaar JK, DeJong CA.  2012.  Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence.. J Addict Dis. 31(1):45-59.
Vruwink FJ, Noorthoorn EO, Nijman HLI, VanDerNagel JEl, Hox JJ, Mulder CL.  2012.  Determinants of seclusion after aggression in psychiatric inpatients.. Arch Psychiatr Nurs. 26(4):307-15.
DeJong CA, Kamal RM, Dijkstra BAG, de Haan HA.  2012.  Gamma-hydroxybutyrate detoxification by titration and tapering.. Eur Addict Res. 18(1):40-5.
2011
Postel MG, de Haan HA, Ter Huurne ED, van der Palen J, Becker ES, DeJong CA.  2011.  Attrition in web-based treatment for problem drinkers.. J Med Internet Res. 13(4):e117.
Postel MG, de Haan HA, Ter Huurne ED, Becker ES, DeJong CA.  2011.  Characteristics of problem drinkers in e-therapy versus face-to-face treatment.. Am J Drug Alcohol Abuse. 37(6):537-42.
de Haan HA, Joosten EAG, Wijdeveld AGM, Boswinkel PB, van der Palen J, DeJong CA.  2011.  Cognitive behavioural treatment is as effective in high- as in low-scoring alexithymic patients with substance-related disorders.. Psychother Psychosom. 80(4):254-5.
Carpentier PJ, Van Gogh MT, Knapen LJM, Buitelaar JK.  2011.  Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.. Eur Addict Res. 17(1):10-20.
Carpentier PJ, Van Gogh MT, Knapen LJM, Buitelaar JK, DeJong CA.  2011.  Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.. Eur Addict Res. 17(1):10-20.
2010
Batalla A, Vera M, Torra M, Parellada E.  2010.  Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis.. J Clin Psychopharmacol. 30(1):92-4.
Postel MG, de Haan HA, Ter Huurne ED, Becker ES, DeJong CA.  2010.  Effectiveness of a web-based intervention for problem drinkers and reasons for dropout: randomized controlled trial.. J Med Internet Res. 12(4):e68.
Iskandar S, Basar D, Hidayat T, Siregar IMP, Pinxten L, van Crevel RR, van der Ven AJAM, DeJong CA.  2010.  High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia.. BMC Public Health. 10:472.
Dijkstra BAG, DeJong CA, Wensing M, Krabbe PFM, van der Staak CP.  2010.  Opioid detoxification: from controlled clinical trial to clinical practice.. Am J Addict. 19(3):283-90.
2009
Linka T, Sartory G, Gastpar M, Scherbaum N, Müller BW.  2009.  Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components.. Psychiatry Res. 169(2):139-43.
Schellekens A, van Oosterwijck AWAA, Ellenbroek B, DeJong CA, Buitelaar JK, Cools AR, Verkes RJ.  2009.  The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls.. Eur Neuropsychopharmacol. 19(1):68-73.
VanDerNagel JEl, Tuts KP, Hoekstra T, Noorthoorn EO.  2009.  Seclusion: the perspective of nurses.. Int J Law Psychiatry. 32(6):408-12.

Pagina's